182 related articles for article (PubMed ID: 10571438)
1. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea.
Linhares AC; Lanata CF; Hausdorff WP; Gabbay YB; Black RE
Pediatr Infect Dis J; 1999 Nov; 18(11):1001-6. PubMed ID: 10571438
[TBL] [Abstract][Full Text] [Related]
2. Rotavirus vaccines and vaccination in Latin America.
Linhares AC; Bresee JS
Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
[TBL] [Abstract][Full Text] [Related]
3. Nutritional status in relation to the efficacy of the rhesus-human reassortant, tetravalent rotavirus vaccine (RRV-TV) in infants from Belém, pará state, Brazil.
Linhares AC; Carmo KB; Oliveira KK; Oliveira CS; Freitas RB; Bellesi N; Monteiro TA; Gabbay YB; Mascarenhas JD
Rev Inst Med Trop Sao Paulo; 2002; 44(1):13-6. PubMed ID: 11896407
[TBL] [Abstract][Full Text] [Related]
4. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
Joensuu J; Koskenniemi E; Pang XL; Vesikari T
Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
[TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
Rennels MB; Wasserman SS; Glass RI; Keane VA
Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
[TBL] [Abstract][Full Text] [Related]
7. Tetravalent human-rhesus reassortant rotavirus vaccine: a review of its immunogenicity, tolerability and protective efficacy against paediatric rotavirus gastroenteritis.
Foster RH; Wagstaff AJ
BioDrugs; 1998 Feb; 9(2):155-78. PubMed ID: 18020551
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations.
Santosham M; Moulton LH; Reid R; Croll J; Weatherholt R; Ward R; Forro J; Zito E; Mack M; Brenneman G; Davidson BL
J Pediatr; 1997 Oct; 131(4):632-8. PubMed ID: 9386673
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ
Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227
[TBL] [Abstract][Full Text] [Related]
11. Rotavirus G serotypes and p[],G genotypes identified in cases of reinfection among children participating in a trial with rhesus-human reassortant tetravalent vaccine (RRV-TV) in Belém, Brazil.
Mascarenhas JD; Leite JP; Gabbay YB; Freitas RB; Oliveira CS; Monteiro TA; Linhares AC
J Trop Pediatr; 2002 Apr; 48(2):93-7. PubMed ID: 12022436
[TBL] [Abstract][Full Text] [Related]
12. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru.
Lanata CF; Midthun K; Black RE; Butron B; Huapaya A; Penny ME; Ventura G; Gil A; Jett-Goheen M; Davidson BL
J Infect Dis; 1996 Aug; 174(2):268-75. PubMed ID: 8699054
[TBL] [Abstract][Full Text] [Related]
13. Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis.
Pang XL; Joensuu J; Hoshino Y; Kapikian AZ; Vesikari T
J Clin Virol; 1999 Jun; 13(1-2):9-16. PubMed ID: 10405887
[TBL] [Abstract][Full Text] [Related]
14. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
[TBL] [Abstract][Full Text] [Related]
15. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.
Joensuu J; Koskenniemi E; Vesikari T
Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus vaccines against diarrhoeal disease.
Vesikari T
Lancet; 1997 Nov; 350(9090):1538-41. PubMed ID: 9388411
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
[TBL] [Abstract][Full Text] [Related]
18. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial.
Pang XL; Joensuu J; Vesikari T
Pediatr Infect Dis J; 1999 May; 18(5):420-6. PubMed ID: 10353514
[TBL] [Abstract][Full Text] [Related]
19. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
[TBL] [Abstract][Full Text] [Related]
20. Review of rotavirus vaccine trials in Finland.
Vesikari T; Joensuu J
J Infect Dis; 1996 Sep; 174 Suppl 1():S81-7. PubMed ID: 8752295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
